Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06522984
NA

Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid

Sponsor: Egymedicalpedia

View on ClinicalTrials.gov

Summary

Melasma is a common acquired disorder of hyperpigmentaion caused by increased melanin production by melanocytes. Melasma is a name derived from the Greek word melas meaning black.It is characterized by the appearance of brownish or grayish symmetrical patches on sun-exposed skin, most commonly on the face. Compared to men, women are more likely to be affected.

Official title: Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid in Combination With Topical Hydroquinone for Refractory Melasma

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-06-01

Completion Date

2025-06-10

Last Updated

2024-07-26

Healthy Volunteers

No

Interventions

DRUG

Tranexamic acid injection

to evaluate and compare efficacy of: * Fractional Er: YAG laser combined with topical hydroquinone. * Intradermal injection of tranexamic acid combined with topical hydroquinone cream. * Oral administration of tranexamic acid combined with topical hydroquinone cream. In treating refractory melasma.

Locations (1)

Aswan University hospitals

Aswān, Egypt